SecBot SecBot
DEF 14A ·Filed Oct 30, 2026

CFOR

CapForce Inc.
NEUTRAL
Impact 3/10
Horizondays Processed1d 22h ago SEC0001829126-26-011840
Definitive proxy statement
Actionable Insight • Neutral

Monitor the 2026 Annual Meeting on December 9, 2026; no shareholder proposals or contested items. The controlling shareholder structure (AEI Capital at 78.94%) ensures all management proposals pass. Monitor the 10-K for fiscal 2025 for any material changes in related-party transactions or financial performance.

DirectionNeutral
Confidencehigh
Horizondays

Price Chart

Loading chart...

Executive Summary

CapForce Inc. filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on December 9, 2026. The meeting will consider the election of six director nominees (all incumbents) and ratification of Beckles & Co., Inc. as independent auditor. The proxy reveals a controlling shareholder structure (AEI Capital Ltd. owns 78.94%), extensive related-party transactions with AEI Capital and its affiliates, and an executive compensation program with minimal cash pay but significant equity awards tied to stock price appreciation. The Board held no formal meetings in fiscal 2025. No shareholder proposals are on the ballot.

Key Facts

  • Annual Meeting scheduled for December 9, 2026; record date October 19, 2026.
  • 12,462,346 common shares and 250 Series D Preferred shares outstanding; Series D carries 244.4 votes per share.
  • AEI Capital Ltd. beneficially owns 78.94% of common stock; CEO John Tan Honjian is its ultimate beneficial owner.
  • All six director nominees are incumbents: John Tan Honjian, Victor Chua Kok Hoe, Ken Lim Zhao Qi, Ethan Low Yu Jie, Constance Wong Poh Yin, and Mohd Azham Azudin.
  • Board determined only Victor Chua and Ken Lim are independent directors; company operates as a controlled company.
  • Board and its committees held no formal meetings during fiscal 2025.
  • CEO John Tan Honjian's 2025 total compensation was $25,000 (all consulting fees); CFO/other NEOs had total compensation of $52,167 (Bonte), $12,500 (Azudin), $40,001 (Syed Johan).
  • Compensation Actually Paid (CAP) for PEO in 2025 was $514,303; average for non-PEO NEOs was $322,499.
  • Net income was $23.6 million in 2025 vs $11,993 in 2024.
  • Total shareholder return on $100 investment: $378.57 in 2025 vs $2.13 in 2024.
  • Related-party transactions include a $12.3M acquisition of iCapX from AEI Capital, a $9.0M securities purchase agreement with AEI Capital, and advisory fees from Client A and Client B where AEI Capital and directors have interests.
  • Audit fees for 2025 were $104,250; Beckles & Co. is the auditor.
  • No shareholder proposals are on the ballot.
  • Section 16(a) delinquent filings: Forms 4 for six directors/officers filed late on July 6, 2026 for a December 2025 transaction; a Form 4 for AEI Capital Ltd. not yet filed for a December 11, 2025 transaction.
  • 2026 Stock Incentive Plan approved at 2025 Annual Meeting on February 23, 2026; 1,000,000 shares authorized with 5% evergreen.
  • The company is a smaller reporting company and did not use financial performance measures to link compensation to performance.

Financial Impact

No material financial data provided; the filing is a routine proxy; no financial impact.

Risk Factors

  • Controlling shareholder structure limits minority shareholder influence; minority shareholders have limited influence over director elections or other proposals.
  • Extensive related-party transactions with AEI Capital and its affiliates create potential conflict-of-interest risks.
  • Board held no formal meetings in fiscal 2025, raising governance concerns.
  • Late Section 16(a) filings indicate potential compliance risk.
  • No independent director diversity policy or formal diversity policy.
  • No lead independent director; CEO also serves as Chairman.
  • No shareholder proposals on the ballot.

Market Snapshot

Exchange
OTC
Sector
Services-Medical Laboratories
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEF 14A Filing (Primary)0001829126-26-011840
Document: 0001829126-26-011840-index-headers.html0001829126-26-011840
Document: 0001829126-26-011840-index.html0001829126-26-011840
Document: 0001829126-26-011840.txt0001829126-26-011840

US Market Status

Market Closed · Opens Mon (18h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026